Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg (Q39865711)

15 September 2017

title

Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg (English)

1 reference

15 September 2017

Gregoire Biollaz

1

1 reference

15 September 2017

Luca Bernasconi

2

1 reference

15 September 2017

Christine Cretton

3

1 reference

15 September 2017

Ursula Püntener

4

1 reference

15 September 2017

Karl Frei

5

1 reference

15 September 2017

Adriano Fontana

6

1 reference

15 September 2017

Tobias Suter

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

European Journal of Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

39

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

1323-1333

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Transmission of glioblastoma multiforme through liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Tumour escape from immune surveillance through dendritic cell inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Bronchiolo-alveolar carcinoma: an analysis of survival predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Microglial cell activation and proliferation precedes the onset of CNS autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Microglia only weakly present glioma antigen to cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

7 January 2021

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

7 January 2021

Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

7 January 2021

Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

7 January 2021

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

7 January 2021

Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838921

7 January 2021

Identifiers

DOI

10.1002/EJI.200838921

1 reference

15 September 2017

1 reference